Published in Am J Transplant on July 01, 2008
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30
Vascularized composite tissue allotransplantation--state of the art. Clin Transplant (2013) 0.90
Codominant Role of Interferon-γ- and Interleukin-17-Producing T Cells During Rejection in Full Facial Transplant Recipients. Am J Transplant (2016) 0.89
Insights from computational modeling in inflammation and acute rejection in limb transplantation. PLoS One (2014) 0.84
Immunomodulatory effects of bone marrow-derived mesenchymal stem cells in a swine hemi-facial allotransplantation model. PLoS One (2012) 0.83
Review of the early diagnoses and assessment of rejection in vascularized composite allotransplantation. Clin Dev Immunol (2013) 0.83
Face allotransplantation and burns: a review. J Burn Care Res (2012) 0.81
Mechanisms and mediators of inflammation: potential models for skin rejection and targeted therapy in vascularized composite allotransplantation. Clin Dev Immunol (2012) 0.80
The need for inducing tolerance in vascularized composite allotransplantation. Clin Dev Immunol (2012) 0.79
Kidney-induced cardiac allograft tolerance in miniature swine is dependent on MHC-matching of donor cardiac and renal parenchyma. Am J Transplant (2015) 0.78
Polyclonal Recipient nTregs Are Superior to Donor or Third-Party Tregs in the Induction of Transplantation Tolerance. J Immunol Res (2015) 0.78
Facial and hand allotransplantation. Cold Spring Harb Perspect Med (2014) 0.78
A critical analysis of rejection in vascularized composite allotransplantation: clinical, cellular and molecular aspects, current challenges, and novel concepts. Front Immunol (2013) 0.78
Studies Introducing Costimulation Blockade for Vascularized Composite Allografts in Nonhuman Primates. Am J Transplant (2015) 0.77
Three-year outcomes in kidney transplant patients randomized to steroid-free immunosuppression or steroid withdrawal, with enteric-coated mycophenolate sodium and cyclosporine: the infinity study. J Transplant (2014) 0.77
Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration. Transpl Int (2015) 0.77
Split rejection in vascularized composite allotransplantation. Eplasty (2013) 0.76
Differentiation between acute skin rejection in allotransplantation and T-cell mediated skin inflammation based on gene expression analysis. Biomed Res Int (2015) 0.76
Sensitized recipients exhibit accelerated but not hyperacute rejection of vascularized composite tissue allografts. Transplantation (2011) 0.76
Tacrolimus to Belatacept Conversion Following Hand Transplantation: A Case Report. Am J Transplant (2015) 0.75
Observation of viable alloskin vs xenoskin grafted onto subcutaneous tissue wounds after tangential excision in massive burns. Burns Trauma (2016) 0.75
Minor Antigen Disparities Impede Induction of Long Lasting Chimerism and Tolerance through Bone Marrow Transplantation with Costimulation Blockade. J Immunol Res (2016) 0.75
Hand disease in scleroderma: a clinical correlate for chronic hand transplant rejection. Springerplus (2013) 0.75
Survival of Allogeneic Self-Assembled Cultured Skin. Transplantation (2016) 0.75
Current status of vascularized composite tissue allotransplantation. Burns Trauma (2014) 0.75
Incomplete clonal deletion as prerequisite for tissue-specific minor antigen tolerization. JCI Insight (2016) 0.75
A Comparative Examination of the Clinical Outcome and Histological Appearance of Cryopreserved and Fresh Split-Thickness Skin Grafts. J Burn Care Res (2016) 0.75
Vascularised composite allotransplants: Transplant of upper extremities and face. Indian J Plast Surg (2015) 0.75
Immunomodulatory Role of Mesenchymal Stem Cell Therapy in Vascularized Composite Allotransplantation. J Transplant (2016) 0.75
Immunomodulatory Strategies Directed Toward Tolerance of Vascularized Composite Allografts. Transplantation (2015) 0.75
[Kidney transplant pathology]. Pathologe (2011) 0.75
Longitudinal immunological characterization of the first presensitized recipient of a face transplant. JCI Insight (2017) 0.75
Identifying predictors of high quality care in English general practice: observational study. BMJ (2001) 9.34
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans. Lancet (1997) 5.17
The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res (1986) 4.16
Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes. Ann Intern Med (2000) 3.44
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Measuring safety climate in health care. Qual Saf Health Care (2006) 2.90
Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase. Mol Cell Biol (1999) 2.77
Geriatric care in general practice. A medicosocial survey of 391 patients undertaken by health visitors. J R Coll Gen Pract (1969) 2.65
Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Ann Intern Med (1995) 2.61
Insurance matters for low-income adults: results from a five-state survey. Health Aff (Millwood) (1997) 2.60
The morphology of "acute tubular necrosis" in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore) (1979) 2.58
Long-term therapy of chronic hepatitis B with lamivudine. Hepatology (2000) 2.49
Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1995) 2.49
Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression. Am J Transplant (2010) 2.37
Impact of a large-scale immunization initiative in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) JAMA (1998) 2.35
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J (1993) 2.28
Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med (1992) 2.27
Establishment of a gene-trap sequence tag library to generate mutant mice from embryonic stem cells. Nat Genet (2000) 2.22
Long-term therapy of chronic delta hepatitis with peginterferon alfa. Aliment Pharmacol Ther (2014) 2.19
Epidemiology of incident spinal fracture in a complete population. Spine (Phila Pa 1976) (1996) 2.12
Role of the T-cell receptor in kidney ischemia-reperfusion injury. Kidney Int (2006) 2.10
Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology (1999) 2.04
Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B. Aliment Pharmacol Ther (2012) 1.81
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest (1999) 1.80
Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci U S A (1999) 1.79
"Thanatosomes": a unifying morphogenetic concept for tumor hyaline globules related to apoptosis. Hum Pathol (2000) 1.77
Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N Engl J Med (1994) 1.77
NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J Immunol (2000) 1.70
Triple jeopardy: rural, poor, and uninsured. Health Serv Res (1989) 1.69
Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin Exp Immunol (2008) 1.68
Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. Am J Transplant (2008) 1.65
High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res (1995) 1.65
Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells. Br J Pharmacol (2010) 1.65
Anaesthesia for children with epidermolysis bullosa: a review of 20 years' experience. Eur J Anaesthesiol (2001) 1.64
Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry (1994) 1.63
Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation (2001) 1.62
Non-urinary tract infections caused by multiply antibiotic-resistant Corynebacterium urealyticum. Clin Infect Dis (1993) 1.62
Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant (2001) 1.60
E-cadherin and adenomatous polyposis coli mutations are synergistic in intestinal tumor initiation in mice. Gastroenterology (2000) 1.57
Milia-like idiopathic calcinosis cutis. Pediatr Dermatol (2004) 1.57
Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J Immunol (2000) 1.55
Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation. Proc Natl Acad Sci U S A (1992) 1.55
Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2008) 1.54
Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol (1998) 1.54
Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques. Am J Transplant (2012) 1.54
External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment. Arch Dermatol (1997) 1.53
The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization. Kidney Int (2007) 1.53
Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet. J Natl Cancer Inst (1992) 1.51
Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant. Am J Transplant (2011) 1.51
Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. Am J Transplant (2014) 1.50
The Maryland aggregate pathology index: a deceased donor kidney biopsy scoring system for predicting graft failure. Am J Transplant (2008) 1.48
Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation. Am J Transplant (2010) 1.48
Array-based ELISAs for high-throughput analysis of human cytokines. Biotechniques (2001) 1.48
Dysplastic tubular epithelium in "normal" kidney associated with renal cell carcinoma. Am J Surg Pathol (1994) 1.47
'Solitary' necrotic nodules of the liver: an aetiology reaffirmed. Gut (1991) 1.46
10-Year follow-up after interferon-alpha therapy for chronic hepatitis C. Hepatology (1998) 1.44
Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant (2007) 1.44
Lamivudine for chronic delta hepatitis. Hepatology (1999) 1.44
Immunization performance measurement in a changing immunization environment. Pediatrics (1999) 1.43
A new look at blockade of T-cell costimulation: a therapeutic strategy for long-term maintenance immunosuppression. Am J Transplant (2006) 1.40
Diagnosing Pemphigus foliaceus: a retrospective analysis of clinical, histological and immunological criteria. Dermatology (2001) 1.40
The inductive properties of mesoderm suggest that the neural crest cells are specified by a BMP gradient. Dev Biol (1998) 1.39
Effects of nitric oxide synthase inhibition on the cardiovascular response to low output shock. Crit Care Med (1996) 1.38
Prostate-specific antigen in the assessment of organ donors. Transplant Proc (2003) 1.38
[Hyperoxia during anesthesia]. Rev Esp Anestesiol Reanim (2007) 1.38
Clonal characteristics of fibrous plaques and fatty streaks from human aortas. Am J Pathol (1975) 1.37
Geriatric care in a welfare home. Ulster Med J (1972) 1.36
Medicare, Medicaid, and the elderly poor. Health Care Financ Rev (1996) 1.35
Skin cancer in organ transplant recipients--where do we stand today? Am J Transplant (2008) 1.35
What's next in the pipeline. Am J Transplant (2008) 1.32
ELISA for quantitation of L-selectin shed from leukocytes in vivo. J Immunol Methods (1992) 1.32
Dysfunctional LAD-1 neutrophils and colitis. Gastroenterology (2001) 1.30
Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold. Am J Transplant (2009) 1.29
Telomere shortening in kidneys with age. J Am Soc Nephrol (2000) 1.29
Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am J Transplant (2001) 1.28
Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa. Gastroenterology (1997) 1.28
Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal Biochem (1997) 1.26
Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection. Am J Transplant (2011) 1.25
IFN-gamma alters the pathology of graft rejection: protection from early necrosis. J Immunol (2001) 1.25
Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes (1999) 1.25
Immunohistochemical study of CD34-positive dendritic cells of human dermis. Am J Dermatopathol (1996) 1.25
Neovascularization and the appearance of morphological characteristics of the blood-brain barrier in the embryonic mouse central nervous system. Brain Res Dev Brain Res (1993) 1.24
Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice. J Immunol (2001) 1.24
Cannabis arteritis. Br J Dermatol (2005) 1.24
The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection. Transplantation (1990) 1.24
Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med (1994) 1.24
Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques. Am J Transplant (2011) 1.23
Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis. Clin Exp Metastasis (1998) 1.22
Medullary plasma flow and intravascular leukocyte accumulation in acute renal failure. Kidney Int (1974) 1.21
Effect of D-alanine methionine enkephalin amide on ion transport in rabbit ileum. J Clin Invest (1980) 1.20